Mukka Proteins Share Price
Sector: Food Processing
32.91 -0.11 (-0.33%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
32.50
Today’s High
33.01
52 Week Low
28.50
52 Week High
56.52
32.81 -0.20 (-0.61%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
32.51
Today’s High
33.04
52 Week Low
28.71
52 Week High
56.56
Key Metrics
- Market Cap (In Cr) 984.91
- Beta -
- Div. Yield (%) 0
- P/B 2.5
- TTM P/E 20.55
- Peg Ratio 0.17
- Sector P/E 20.94
- Open Price 32.6
- Prev Close 33.02
Mukka Proteins Analysis
Price Analysis
-
1 Week-0.18%
-
3 Months-9.24%
-
6 Month-21.31%
-
YTD-19.96%
-
1 Year-11.14%
Risk Meter
- 38% Low risk
- 38% Moderate risk
- 38% Balanced Risk
- 38% High risk
- 38% Extreme risk
Mukka Proteins News
Mukka Proteins Limited Reports 151% Profit Increase in Q3 FY2024-25
1 min read . 05 Mar 2025Budget 2025: Fisheries stocks surge up to 12% on positive budget announcements
3 min read . 01 Feb 2025MUKKA PROTEINS share price Today Live Updates : MUKKA PROTEINS Shares Drop in Trading Today
1 min read . 19 Mar 2024Mukka Proteins Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1379.83
- Selling/ General/ Admin Expenses Total
- 34.34
- Depreciation/ Amortization
- 12.3
- Other Operating Expenses Total
- 82.4
- Total Operating Expense
- 1285.79
- Operating Income
- 94.04
- Net Income Before Taxes
- 87.46
- Net Income
- 70.05
- Diluted Normalized EPS
- 2.32
- Period
- 2024
- Total Assets
- 940.79
- Total Liabilities
- 544.7
- Total Equity
- 396.09
- Tangible Book Valueper Share Common Eq
- 13.2
- Period
- 2024
- Cashfrom Operating Activities
- -150.41
- Cashfrom Investing Activities
- -47.59
- Cashfrom Financing Activities
- 265.89
- Net Changein Cash
- 67.89
- Period
- 2023
- Total Revenue
- 1177.12
- Selling/ General/ Admin Expenses Total
- 28.75
- Depreciation/ Amortization
- 11.85
- Other Operating Expenses Total
- 98.11
- Total Operating Expense
- 1094.58
- Operating Income
- 82.54
- Net Income Before Taxes
- 65.94
- Net Income
- 44.08
- Diluted Normalized EPS
- 1.44
- Period
- 2023
- Total Assets
- 575.16
- Total Liabilities
- 427.36
- Total Equity
- 147.8
- Tangible Book Valueper Share Common Eq
- 4.93
- Period
- 2023
- Cashfrom Operating Activities
- -54.39
- Cashfrom Investing Activities
- -5.26
- Cashfrom Financing Activities
- 74.66
- Net Changein Cash
- 15.01
- Period
- 2022
- Total Revenue
- 770.5
- Selling/ General/ Admin Expenses Total
- 21.65
- Depreciation/ Amortization
- 8.54
- Other Operating Expenses Total
- 58.64
- Total Operating Expense
- 728.55
- Operating Income
- 41.96
- Net Income Before Taxes
- 35.98
- Net Income
- 24.21
- Diluted Normalized EPS
- 0.78
- Period
- 2022
- Total Assets
- 392.3
- Total Liabilities
- 293.93
- Total Equity
- 98.37
- Tangible Book Valueper Share Common Eq
- 3.28
- Period
- 2022
- Cashfrom Operating Activities
- 4.81
- Cashfrom Investing Activities
- -12.28
- Cashfrom Financing Activities
- 15.86
- Net Changein Cash
- 8.38
- Period
- 2021
- Total Revenue
- 603.83
- Selling/ General/ Admin Expenses Total
- 17.25
- Depreciation/ Amortization
- 8.3
- Other Operating Expenses Total
- 43.11
- Total Operating Expense
- 585.75
- Operating Income
- 18.08
- Net Income Before Taxes
- 15.46
- Net Income
- 8.98
- Diluted Normalized EPS
- 0.2
- Period
- 2021
- Total Assets
- 353.93
- Total Liabilities
- 288.27
- Total Equity
- 65.66
- Tangible Book Valueper Share Common Eq
- 2.19
- Period
- 2021
- Cashfrom Operating Activities
- 5.95
- Cashfrom Investing Activities
- -13.61
- Cashfrom Financing Activities
- 9.32
- Net Changein Cash
- 1.66
- Period
- 2020
- Total Revenue
- 549.25
- Selling/ General/ Admin Expenses Total
- 9.99
- Depreciation/ Amortization
- 4.65
- Other Operating Expenses Total
- 32.87
- Total Operating Expense
- 529.02
- Operating Income
- 20.22
- Net Income Before Taxes
- 19.73
- Net Income
- 13.18
- Diluted Normalized EPS
- 0.44
- Period
- 2020
- Total Assets
- 293.12
- Total Liabilities
- 236.57
- Total Equity
- 56.55
- Tangible Book Valueper Share Common Eq
- 1.88
- Period
- 2020
- Cashfrom Operating Activities
- -25.07
- Cashfrom Investing Activities
- -27.97
- Cashfrom Financing Activities
- 53.79
- Net Changein Cash
- 0.74
- Period
- 2019
- Total Revenue
- 408.79
- Selling/ General/ Admin Expenses Total
- 7.28
- Depreciation/ Amortization
- 2.39
- Other Operating Expenses Total
- 21.6
- Total Operating Expense
- 387.92
- Operating Income
- 20.87
- Net Income Before Taxes
- 18.8
- Net Income
- 14.29
- Diluted Normalized EPS
- 0.49
- Period
- 2019
- Total Assets
- 200.84
- Total Liabilities
- 156.86
- Total Equity
- 43.99
- Tangible Book Valueper Share Common Eq
- 1.46
- Period
- 2019
- Cashfrom Operating Activities
- -20.27
- Cashfrom Investing Activities
- -23.16
- Cashfrom Financing Activities
- 34.2
- Net Changein Cash
- -9.24
- Period
- 2024-12-31
- Total Revenue
- 303.15
- Selling/ General/ Admin Expenses Total
- 8.43
- Depreciation/ Amortization
- 3.8
- Other Operating Expenses Total
- 32.48
- Total Operating Expense
- 265.59
- Operating Income
- 37.56
- Net Income Before Taxes
- 32.97
- Net Income
- 26.26
- Diluted Normalized EPS
- 0.88
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 149.19
- Selling/ General/ Admin Expenses Total
- 8.31
- Depreciation/ Amortization
- 3.76
- Other Operating Expenses Total
- 19.07
- Total Operating Expense
- 143.38
- Operating Income
- 5.81
- Net Income Before Taxes
- 1.05
- Net Income
- 2.08
- Diluted Normalized EPS
- 0.07
- Period
- 2024-09-30
- Total Assets
- 904.42
- Total Liabilities
- 505.53
- Total Equity
- 398.89
- Tangible Book Valueper Share Common Eq
- 13.07
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -112.64
- Cashfrom Investing Activities
- -20.98
- Cashfrom Financing Activities
- 44.39
- Net Changein Cash
- -89.24
- Period
- 2024-06-30
- Total Revenue
- 172.5
- Selling/ General/ Admin Expenses Total
- 6.99
- Depreciation/ Amortization
- 3.18
- Other Operating Expenses Total
- 21.11
- Total Operating Expense
- 160.89
- Operating Income
- 11.61
- Net Income Before Taxes
- 6.14
- Net Income
- 4.51
- Diluted Normalized EPS
- 0.15
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 256.7
- Selling/ General/ Admin Expenses Total
- 7.67
- Depreciation/ Amortization
- 3.34
- Other Operating Expenses Total
- 24.94
- Total Operating Expense
- 227.84
- Operating Income
- 28.85
- Net Income Before Taxes
- 26.96
- Net Income
- 27.37
- Diluted Normalized EPS
- 0.91
- Period
- 2024-03-31
- Total Assets
- 940.79
- Total Liabilities
- 544.7
- Total Equity
- 396.09
- Tangible Book Valueper Share Common Eq
- 13.2
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -150.41
- Cashfrom Investing Activities
- -47.59
- Cashfrom Financing Activities
- 265.89
- Net Changein Cash
- 67.89
- Period
- 2023-12-31
- Total Revenue
- 516.99
- Selling/ General/ Admin Expenses Total
- 7.98
- Depreciation/ Amortization
- 3.18
- Other Operating Expenses Total
- 37.11
- Total Operating Expense
- 501.29
- Operating Income
- 15.7
- Net Income Before Taxes
- 17.47
- Net Income
- 10.45
- Diluted Normalized EPS
- 0.35
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 331.82
- Selling/ General/ Admin Expenses Total
- 6.8
- Depreciation/ Amortization
- 3.22
- Other Operating Expenses Total
- 20.47
- Total Operating Expense
- 293.37
- Operating Income
- 38.45
- Net Income Before Taxes
- 35.88
- Net Income
- 28.75
- Diluted Normalized EPS
- 0.95
- Period
- 2023-09-30
- Total Assets
- 641.18
- Total Liabilities
- 461.24
- Total Equity
- 179.94
- Tangible Book Valueper Share Common Eq
- 6
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -20.12
- Cashfrom Investing Activities
- -40.95
- Cashfrom Financing Activities
- 53.65
- Net Changein Cash
- -7.41
- Period
- 2023-03-31
- Total Revenue
- 420.71
- Selling/ General/ Admin Expenses Total
- 9.27
- Depreciation/ Amortization
- 2.91
- Other Operating Expenses Total
- 29.88
- Total Operating Expense
- 378.31
- Operating Income
- 42.4
- Net Income Before Taxes
- 33.02
- Net Income
- 21.86
- Diluted Normalized EPS
- 0.77
- Period
- 2023-03-31
- Total Assets
- 575.16
- Total Liabilities
- 427.36
- Total Equity
- 147.8
- Tangible Book Valueper Share Common Eq
- 4.93
- Period
- 2023-03-31
- Cashfrom Operating Activities
- -54.39
- Cashfrom Investing Activities
- -5.26
- Cashfrom Financing Activities
- 74.66
- Net Changein Cash
- 15.01
- Period
- 2022-12-31
- Total Revenue
- 756.42
- Selling/ General/ Admin Expenses Total
- 19.49
- Depreciation/ Amortization
- 8.94
- Other Operating Expenses Total
- 62.22
- Total Operating Expense
- 710.26
- Operating Income
- 46.16
- Net Income Before Taxes
- 32.92
- Net Income
- 22.22
- Diluted Normalized EPS
- 0.66
- Period
- 2022-12-31
- Total Assets
- 576.31
- Total Liabilities
- 447.16
- Total Equity
- 129.15
- Tangible Book Valueper Share Common Eq
- 4.3
- Period
- 2022-12-31
- Cashfrom Operating Activities
- -58.75
- Cashfrom Investing Activities
- -6.03
- Cashfrom Financing Activities
- 57.91
- Net Changein Cash
- -6.88
- Period
- 2022-03-31
- Total Revenue
- 770.5
- Selling/ General/ Admin Expenses Total
- 21.65
- Depreciation/ Amortization
- 8.54
- Other Operating Expenses Total
- 56.48
- Total Operating Expense
- 726.38
- Operating Income
- 44.12
- Net Income Before Taxes
- 35.98
- Net Income
- 24.21
- Diluted Normalized EPS
- 0.78
- Period
- 2022-03-31
- Total Assets
- 392.3
- Total Liabilities
- 293.93
- Total Equity
- 98.37
- Tangible Book Valueper Share Common Eq
- 3.28
- Period
- 2022-03-31
- Cashfrom Operating Activities
- 4.81
- Cashfrom Investing Activities
- -12.28
- Cashfrom Financing Activities
- 15.86
- Net Changein Cash
- 8.38
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Mukka Proteins Technical
Moving Average
SMA
- 5 Day33.23
- 10 Day33.17
- 20 Day32.96
- 50 Day33.61
- 100 Day36.22
- 300 Day40.25
Mukka Proteins Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Uttam Sugar Mills
- 291
- -0.75
- -0.26
- 395.9
- 170.05
- 1109.82
- Avadh Sugar & Energy
- 564.65
- 13.85
- 2.51
- 830.85
- 354.45
- 1131.16
- Mukka Proteins
- 32.91
- -0.11
- -0.33
- 56.52
- 28.5
- 984.91
- Magadh Sugar & Energy
- 688.05
- 7.15
- 1.05
- 1010
- 440
- 969.58
- Avt Natural Products
- 61.01
- 0.28
- 0.46
- 102.65
- 51
- 934.01
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Uttam Sugar Mills
- 8.41
- 1.6
- 23.6
- 5.23
- Avadh Sugar & Energy
- 8.59
- 1.07
- 13.92
- 3.84
- Mukka Proteins
- 14.2
- 2.5
- 27.27
- 3.84
- Magadh Sugar & Energy
- 7.1
- 1.29
- 11.01
- 6.57
- Avt Natural Products
- 17.35
- 1.97
- 16.21
- 11.13
Mukka Proteins Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-Feb-25
- Quarterly Results & Others
- 14-Nov-24
- Quarterly Results
- 21-Oct-24
- Rights issue of Equity Shares
- 13-Aug-24
- Quarterly Results
- 14-May-24
- Audited Results
- 28-Mar-24
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 16-Nov-24
- 23-Oct-24
- EGM
- 26-Sept-24
- 13-Aug-24
- AGM



